FAQs
|
Site Map
|
Privacy Policy
|
Terms Of Use
English(UK)
|
中文
|
Россию
|
Française
|
Español
|
Deutsch
English
Home
|
About Us
Our DNA
What we do
Our Focus
Message from MD
Management
Accreditations
Presence
|
Services
BA / BE Studies
PK PD and Patient Studies
Bioanalytical Studies
Phase I Studies
Phase II- IV
Biometrics
Medical Writing
Regulatory Services
Quality Assurance
Project Management
Central Lab
|
Therapeutic Areas
|
Expertise
Bio Studies
Phase I / Early Phase
Late Phase
Regulatory Submission
Fact Sheet
|
Careers
Life @ Lotus
Current Openings
|
Contact Us
Expertise
Bio Studies
Phase I / Early Phase
Late Phase
Regulatory Submission
Fact Sheet
Fact Sheet
Over 1,300 studies completed
Over 250 bioanalytical methods developed
Over 42 Regulatory audits
Four clinical facilities in India
2 clinical trials submitted to FDA for approval and few of those sites are audited by FDA
Fact Sheet
Lotus Labs is a client focused and systems driven organization that is committed to provide best-in-class solutions and services to clients at home and abroad.
Our research professionals and support staff are highly qualified and well experienced to ensure successful project delivery with the assurance of quality and reliability at all times.
Lotus Labs has developed robust systems and procedures to guarantee process standardization and adhere to globally recognized guidelines.
Over 1,300 studies completed
Over 250 bioanalytical methods developed
Over 42 Regulatory audits
4 Clinical Facilities in India
BA / BE Studies
Phase I Studies
Phase II - IV Studies
Supplementary Services
Regulatory Services
Central Lab Services
Bioanalytical Services
Biometrics & Medical Writing
Quality Assurance
Lotus Labs has expertise in different formulations such as Solid Oral Formulations – Tablets / Capsules / Soft Gels / Sprinkles IR / ER / DR / SR / PR / XR / MR, Liquid Formulations – Suspensions / Syrups, Parenterals – Intra Muscular / Intra Venous & Subcutaneous, Orally Dispersible Formulations, Sprays – Nasal / Oral, Inhalers and Dermal Patches.